Imaging of tau pathology in a tauopathy mouse model and in alzheimer patients compared to normal controls

Neuron

Volumn 79, Issue 6, 2013, Pages 1094-1108

  Maruyama, Masahiro ^a   Shimada, Hitoshi ^a   Suhara, Tetsuya ^a   Shinotoh, Hitoshi ^a   Ji, Bin ^a   Maeda, Jun ^a   Zhang, Ming Rong ^a   Trojanowski, JohnQ ^b   Lee, VirginiaM Y ^b   Ono, Maiko ^a   Masamoto, Kazuto ^a   Takano, Harumasa ^a   Sahara, Naruhiko ^c,d   Iwata, Nobuhisa ^c   Okamura, Nobuyuki ^e   Furumoto, Shozo ^e   Kudo, Yukitsuka ^f   Chang, Qing ^g   Saido, TakaomiC ^c   Takashima, Akihiko ^c   Lewis, Jada ^d   Jang, Ming Kuei ^g   Aoki, Ichio ^a   Ito, Hiroshi ^a   Higuchi, Makoto ^a   more..

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f TOHOKU UNIVERSITY HOSPITAL   (Japan)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PHENYLPYRIDINYLBUTADIENYLBENZOTHIAZOLE C 13; PHENYLPYRIDINYLBUTADIENYLBENZOTHIAZOLE DERIVATIVE; PITTSBURGH COMPOUND B; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CEREBELLUM; CONTROLLED STUDY; CORTICOBASAL SYNDROME; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DRUG BINDING; DRUG BLOOD LEVEL; DRUG UPTAKE; EX VIVO STUDY; FLUORESCENCE IMAGING; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; SENILE PLAQUE; SENSITIVITY AND SPECIFICITY; TAUOPATHY; TEMPORAL LOBE; WHITE MATTER;

AGE FACTORS; AGED; ALZHEIMER DISEASE; AMINOPYRIDINES; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; ANIMALS; AUTORADIOGRAPHY; BENZOTHIAZOLES; BRAIN; BRAIN MAPPING; CARBON ISOTOPES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MUTATION; POSITRON-EMISSION TOMOGRAPHY; PROTEIN STRUCTURE, SECONDARY; TAU PROTEINS; TAUOPATHIES; THIAZOLES;

EID: 84884273839     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.07.037     Document Type: Article

References (27)

1. Bacskai B.J., Hickey G.A., Skoch J., Kajdasz S.T., Wang Y., Huang G.F., Mathis C.A., Klunk W.E., Hyman B.T. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice. Proc. Natl. Acad. Sci. USA 2003, 100:12462-12467.
2. Ballatore C., Lee V.M.Y., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8:663-672.
3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
4. Braak H., Thal D.R., Ghebremedhin E., Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J.Neuropathol. Exp. Neurol. 2011, 70:960-969.
5. Chien D.T., Bahri S., Szardenings A.K., Walsh J.C., Mu F., Su M.Y., Shankle W.R., Elizarov A., Kolb H.C. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J.Alzheimers Dis. 2013, 34:457-468.
6. Dickson D.W., Kouri N., Murray M.E., Josephs K.A. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J.Mol. Neurosci. 2011, 45:384-389.
7. Engler H., Forsberg A., Almkvist O., Blomquist G., Larsson E., Savitcheva I., Wall A., Ringheim A., Långström B., Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain 2006, 129:2856-2866.
8. 18F-THK523: a novel invivo tau imaging ligand for Alzheimer's disease. Brain 2011, 134:1089-1100.
9. 1H MRI detection of amyloid β plaques invivo. Nat. Neurosci. 2005, 8:527-533.
10. Hintersteiner M., Enz A., Frey P., Jaton A.L., Kinzy W., Kneuer R., Neumann U., Rudin M., Staufenbiel M., Stoeckli M., et al. Invivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe. Nat. Biotechnol. 2005, 23:577-583.
11. Klunk W.E., Wang Y., Huang G.F., Debnath M.L., Holt D.P., Shao L., Hamilton R.L., Ikonomovic M.D., DeKosky S.T., Mathis C.A. The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J.Neurosci. 2003, 23:2086-2092.
12. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergström M., Savitcheva I., Huang G.F., Estrada S., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
13. Krebs M.R.H., Bromley E.H., Donald A.M. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J.Struct. Biol. 2005, 149:30-37.
14. Kudo Y., Okamura N., Furumoto S., Tashiro M., Furukawa K., Maruyama M., Itoh M., Iwata R., Yanai K., Arai H. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for invivo detection of dense amyloid plaques in Alzheimer's disease patients. J.Nucl. Med. 2007, 48:553-561.
15. Maeda J., Ji B., Irie T., Tomiyama T., Maruyama M., Okauchi T., Staufenbiel M., Iwata N., Ono M., Saido T.C., et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J.Neurosci. 2007, 27:10957-10968.
16. Maeda J., Zhang M.R., Okauchi T., Ji B., Ono M., Hattori S., Kumata K., Iwata N., Saido T.C., Trojanowski J.Q., et al. Invivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. J.Neurosci. 2011, 31:4720-4730.
17. Marx J. Alzheimer's disease. A new take on tau. Science 2007, 316:1416-1417.
18. Okamura N., Suemoto T., Furumoto S., Suzuki M., Shimadzu H., Akatsu H., Yamamoto T., Fujiwara H., Nemoto M., Maruyama M., et al. Quinoline and benzimidazole derivatives: candidate probes for invivo imaging of tau pathology in Alzheimer's disease. J.Neurosci. 2005, 25:10857-10862.
19. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
20. Schmidt M.L., Gur R.E., Gur R.C., Trojanowski J.Q. Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens. Ann. Neurol. 1988, 23:184-189.
21. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., et al. PET of brain amyloid and tau in mild cognitive impairment. N.Engl. J. Med. 2006, 355:2652-2663.
22. Suzuki K., Takei M., Kida T. Development of an analyzing system for the sensitive measurement of radioactive metabolites on the PET study. J.Labelled Comp. Radiopharm. 1999, 42:S658-S660.
23. Thompson P.W., Ye L., Morgenstern J.L., Sue L., Beach T.G., Judd D.J., Shipley N.J., Libri V., Lockhart A. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. J.Neurochem. 2009, 109:623-630.
24. Yang L., Rieves D., Ganley C. Brain amyloid imaging-FDA approval of florbetapir F18 injection. N.Engl. J. Med. 2012, 367:885-887.
25. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M.Y. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
26. Zhang W., Arteaga J., Cashion D.K., Chen G., Gangadharmath U., Gomez L.F., Kasi D., Lam C., Liang Q., Liu C., et al. A highly selective and specific PET tracer for imaging of tau pathologies. J.Alzheimers Dis. 2012, 31:601-612.
27. Zhuang Z.P., Kung M.P., Hou C., Skovronsky D.M., Gur T.L., Plössl K., Trojanowski J.Q., Lee V.M.Y., Kung H.F. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J.Med. Chem. 2001, 44:1905-1914.